Add to ORKGThis is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License (www.karger.com/OA-license), applicable to the online version of the article only. Distribution for non-commercial purposes only
Drug delivery into the vitreous chamber remains a great challenge in the pharmaceutical industry due...
This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonComme...
Dexamethasone intravitreal implant is a biodegradable dexamethasone(DEX)0.7mg slow-release implant t...
www.karger.com/cop This is an Open Access article licensed under the terms of the Creative Commons A...
To evaluate the long-term results of intravitreal dexamethasone implant (DEX) for noninfectious uvei...
www.karger.com/cop This is an Open Access article licensed under the terms of the Creative Commons A...
Copyright © 2015 Solmaz Abdolrahimzadeh et al. This is an open access article distributed under the ...
Drug delivery into the vitreous chamber remains a great challenge in the pharmaceutical industry due...
Full copyright for enhanced digital features is owned by the authors. Provide enhanced digital ...
Purpose: To report the efficacy of intravitreal dexamethasone implant in a patient with retinitis pi...
Purpose: To report the efficacy of intravitreal dexamethasone implant in a patient with retinitis pi...
Drug delivery into the vitreous chamber remains a great challenge in the pharmaceutical industry due...
Full copyright for enhanced digital features is owned by the authors. Article full text The fu...
Drug delivery into the vitreous chamber remains a great challenge in the pharmaceutical industry due...
Drug delivery into the vitreous chamber remains a great challenge in the pharmaceutical industry due...
Drug delivery into the vitreous chamber remains a great challenge in the pharmaceutical industry due...
This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonComme...
Dexamethasone intravitreal implant is a biodegradable dexamethasone(DEX)0.7mg slow-release implant t...
www.karger.com/cop This is an Open Access article licensed under the terms of the Creative Commons A...
To evaluate the long-term results of intravitreal dexamethasone implant (DEX) for noninfectious uvei...
www.karger.com/cop This is an Open Access article licensed under the terms of the Creative Commons A...
Copyright © 2015 Solmaz Abdolrahimzadeh et al. This is an open access article distributed under the ...
Drug delivery into the vitreous chamber remains a great challenge in the pharmaceutical industry due...
Full copyright for enhanced digital features is owned by the authors. Provide enhanced digital ...
Purpose: To report the efficacy of intravitreal dexamethasone implant in a patient with retinitis pi...
Purpose: To report the efficacy of intravitreal dexamethasone implant in a patient with retinitis pi...
Drug delivery into the vitreous chamber remains a great challenge in the pharmaceutical industry due...
Full copyright for enhanced digital features is owned by the authors. Article full text The fu...
Drug delivery into the vitreous chamber remains a great challenge in the pharmaceutical industry due...
Drug delivery into the vitreous chamber remains a great challenge in the pharmaceutical industry due...
Drug delivery into the vitreous chamber remains a great challenge in the pharmaceutical industry due...
This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonComme...
Dexamethasone intravitreal implant is a biodegradable dexamethasone(DEX)0.7mg slow-release implant t...